Researchers Developed A Novel Class Of Synthetic Molecules That Target Prostate Cancer Cells

Researchers Developed A Novel Class Of Synthetic Molecules That Target Prostate Cancer Cells
shutterstock_127353983A novel class of synthetic molecules with the targeting and effector functions of antibodies were synthesized to induce a highly targeted immune response against prostate cancer. The study entitled “Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies” was published in the Journal of the American Chemical Society by Patrick J. McEnaney part of Dr. David A. Spiegel’s group, and colleagues. The team engineered a class of new molecules, called synthetic antibody mimics (SyAMs) that bind simultaneously to unhealthy cells and cells from the immune system. This interaction leads to a very specific targeted immune response like the one seen with natural human antibodies. In this study the main focus was the use of SyAM molecules to target prostate cancer, termed SyAM-Ps, which recognize tumor cells by binding to a specific protein, the prostate-specific membrane antigen (PSMA), on the surface of the transformed cells, and to the Fc gamma receptor on the surface of the immune cell. This binding elicits a high selective cancer cell phagocytosis and consequently, the death of the malignant cell. "Unlike antibodies, how
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *